SCHEMBL31269059

SCHEMBL31269059

CC(=O)NCCOc1ccc(-c2nc3c(OC4(C)CC4)ncnc3n2Cc2cc(C)ccn2)c(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 2/20 0.34
▸ LMNA P02545 1/20 0.33
▸ PDK2 Q15119 2/20 0.33
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA2 P54646 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAG3 Q9UGI9 1/20 0.32
▸ PRKAG2 Q9UGJ0 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ CNR1 P21554 2/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ ACSS2 Q9NR19 1/20 0.31
▸ RET P07949 1/20 0.31
▸ MTNR1A P48039 2/20 0.31
▸ MTNR1B P49286 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31268953 0.98 PDK2 (0.33) PIK3CDLMNAPDK2PRKAB2PRKAG1
SCHEMBL31269108 0.94 PIK3CD (0.33) PIK3CDCNR1CNR2CYP1A2CYP3A4
SCHEMBL31268772 0.92 PIK3CD (0.32) PIK3CDCYP1A2CYP3A4GAACYP2C9
SCHEMBL31268874 0.90 KDM4E (0.32) PIK3CDLMNAALDH1A1
SCHEMBL31269111 0.90 HRH4 (0.32) PIK3CDLMNAALDH1A1
SCHEMBL31269170 0.89 PIK3CD (0.34) PIK3CDCNR1CNR2MTNR1AMTNR1B
SCHEMBL31268819 0.89 PIK3CD (0.36) PIK3CD
SCHEMBL30983456 0.89 PIK3CD (0.35) PIK3CD
SCHEMBL31268908 0.89 KCNJ5 (0.33) PIK3CDCNR1CNR2ALK
SCHEMBL31268935 0.88 PDE2A (0.34) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback